Loading...

SUDARSHAN Sudarshan Pharma Industries Ltd Capital Structure Changes Announcement

Sdrs

SDRS

Sudarshan Pharma Industries Ltd

(SUDARSHAN)

2025 Announcement

Show Summary

Summary

AGM Announcement

New Subsidiary Formation

US Subsidiary Launch

Fundraising Proposal

One Star Export House

Annual Compliance Report

Investor Meet Announcement

Acquisition Update

Management Change

Investor Presentation

Management Change

Financial Results Publication

Compliance Certificate

Equity Acquisition

Directorate Change

Market Maker Change

Investor Meeting

Management Change

CFO Resignation

Investor Meeting

Acquisition Update

Poland Subsidiary Setup

Securities Issue Update

Technology Agreement

Acquisition of Cibachem

EGM Notice Published

Investor Presentation

Subsidiary Acquisition

Management Resignation

Extraordinary General Meeting

Stake Acquisition

New Subsidiary Established

Lawsuit Victory

Investor Presentation

Certificate Received

Fundraising Approval

Completion of R&D Milestone

Financial Results Publication

New Management Appointments...

Certificate Compliance

Compliance Certificate

Certificate Submission

Management Change

Resignation Notification

Resignation Announcement

Certificate Submission

Business Update at CPHI 2023

Business Update

Newspaper Advertisement

Delay in Import of Material

Investor Presentation

Delay in Payment

Resignation of Director

Appointment and Resignation

Management Changes

Newspaper Advertisement

Board Meeting Outcome

Management Changes

Board Meeting Outcome

Compliance Certificate Subm...

Business Update

Certificate Submission

Resignation of CFO

Resignation of CFO

Investor Presentation

Subsidiary Incorporation

Financial Statements

Asset Acquisitions

Asset Acquisitions

Asset Acquisition

Investments under Governmen...

First milestone completion

Other Special Situation

Dividend Policy Change

Dividend Payment

Dividend policy change

Regulatory Compliance

Financial Results Publication

Changes in Cost Recognition

Management Changes

External Links:

Data:

Sudarshan Pharma Industries Ltd has approved the revision of allotees and issued a corrigendum for an Extraordinary General Meeting on February 4, 2025, regarding a preferential issue of 4,30,00,000 fully convertible warrants at Rs. 43.80 each, totaling Rs. 188.34 Crores.

AI Assistant

Sudarshan Pharma Industries Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.